Abstract
Streptococcus pneumoniae is the leading cause of community-acquired pneumonia. The pore-forming cholesterol-dependent cytolysin (CDC) pneumolysin (PLY) and the physiological metabolite hydrogen peroxide (H(2)O(2)) can greatly increase the virulence of pneumococci. Although most studies have focused on the contribution of both virulence factors to the course of pneumococcal infection, it is unknown whether or how H(2)O(2) can affect PLY activity. Of note, S. pneumoniae exploits endogenous H(2)O(2) as an intracellular signalling molecule to modulate the activity of several proteins. Here, we demonstrate that H(2)O(2) negatively affects the haemolytic activity of PLY in a concentration-dependent manner. Prevention of cysteine-dependent sulfenylation upon substitution of the unique and highly conserved cysteine residue to serine in PLY significantly reduces the toxin's susceptibility to H(2)O(2) treatment and completely abolishes the ability of DTT to activate PLY. We also detect a clear gradual correlation between endogenous H(2)O(2) generation and PLY release, with decreased H(2)O(2) production causing a decline in the release of PLY. Comparative transcriptome sequencing analysis of the wild-type S. pneumoniae strain and three mutants impaired in H(2)O(2) production indicates enhanced expression of several genes involved in peptidoglycan (PG) synthesis and in the production of choline-binding proteins (CPBs). One explanation for the impact of H(2)O(2) on PLY release is the observed upregulation of the PG bridge formation alanyltransferases MurM and MurN, which evidentially negatively affect the PLY release. Our findings shed light on the significance of endogenous pneumococcal H(2)O(2) in controlling PLY activity and release.